Summary
A case study describing a Phase I dose escalation and cohort expansion study of an immune checkpoint inhibitor in patients with advanced solid tumors.
Register to download
Successful Adaptation to the Evolution of Complex Dose Escalation Within a Large Master Protocol Basket Design Across IO Co-Therapies
You may also be interested in:
White Paper
Strategies for Accelerating Rare Disease Clinical Development
Rare disease trials differ from those in most other therapeutic areas because the indications are more complex and involve smaller patient…
View Resource
Blog
International Nurses Day 2020: Former Nurses Share Experiences on the Frontlines
As part of our contribution to International Nurses Day, we spoke with a few of our 2,300 PRA employees with nursing backgrounds. They share what…
Read Story
White Paper
Pharmacogenomics in Pain Management
Pharmacogenomics in Pain Management. In the US alone there are an estimated 100 million adults suffering from chronic pain. Pharmacogenomics and…
View Resource
View all related content and resources for Medical Affairs
Explore Insights